First-Line Gefitinib for Patients With Advanced Non–Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations Without Indication for ChemotherapyAkira Inoue, Koichi Hagiwara, Tomoaki Tanaka et al.|Journal of Clinical Oncology|2009Cited by 516
Randomized Phase II Trial Comparing Amrubicin With Topotecan in Patients With Previously Treated Small-Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 0402Akira Inoue, Toshihiro Nukiwa, Yasuo Saijo et al.|Journal of Clinical Oncology|2008Cited by 235
Combined Survival Analysis of Prospective Clinical Trials of Gefitinib for Non–Small Cell Lung Cancer with <i>EGFR</i> MutationsSatoshi Morita, Toshihiro Nukiwa, Kimihide Yoshida et al.|Clinical Cancer Research|2009Cited by 189